Lantern Laboratory is developing a novel device/platform utilizing EEG biomarkers to specifically guide pharmacological decisions during administration of analgesics and sedatives in operating rooms and intensive care, resulting in faster, safer awakenings from anesthesia, less postoperative neurocognitive dysfunction, and a reduction in the lifetime risk of dementia in those undergoing surgery or ICU stay.